Read more

April 23, 2020
2 min read
Save

Total elbow arthroplasty yielded high complication, revision rate among young patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Despite satisfactory results among younger patients who underwent total elbow arthroplasty, published results showed patients had a high rate of complications and revisions.

Perspective from Jay D. Keener, MD

Researchers assessed the indication for further surgery, range of motion, mean Mayo Elbow Performance Score, QuickDASH score, radiolucent lines and outcomes measures that included implant survival, complications and revisions among 19 total elbow arthroplasties (Conrad-Morrey Total Elbow, Zimmer-Biomet) implanted in 17 patients younger than 55 years of age between 1998 and 2008.

At an average follow-up of 10 years, results showed a significant improvement in average range of motion from 120° to 140° for flexion and from 40° to 25° for extension. Researchers found patients had an average Mayo Elbow Performance Score of 85. Complications occurred in 56% of elbows, of which 42% underwent revision, according to results. Researchers noted aseptic loosening as the main indication for revision. Results showed a survivorship rate without revision of 94% at 5 years and of 75% at 10 years.

Younger patients who underwent total elbow arthroplasty had a survivorship rate without revision of 94% at 5 years and 75% at 10 years, according to results.
Younger patients who underwent total elbow arthroplasty had a survivorship rate without revision of 94% at 5 years and 75% at 10 years, according to results.

“[Total elbow arthroplasty] TEA should be considered with caution in younger patients,” the authors wrote. “Alternative therapeutic options must be discussed if possible.” – by Casey Tingle

 

Disclosures: The authors report no relevant financial disclosures.